Starting in October 2022, Dormi is the new service available within the Center for Sleep Disorders at Santagostino Medical Centers.
The Santagostino is an italian network of comprehensive specialty outpatient, known for the high quality and affordable rates of its services. Founded in 2009, the Santagostino medical centers offers advanced imaging diagnostics and therapeutic options tailored to the patients’ needs, created to respond to a growing unmet need of a large part of the population: high-level, affordable specialist medicine that also covers areas uncovered by the Public healthcare system. Sleepacta responds perfectly to Santagostino’s mission of relying on innovation to provide advanced solutions that improve the work of healthcare professionals and the quality of life of patients (https://www.santagostino.it/it/news/un-algoritmo-per-dormire-meglio).
Sleep is Sleepacta’s ‘artificial intelligence algorithm that analyzes and reprocesses all physiological data collected during sleep, reporting a true snapshot of the patient’s sleep through an examination called Actigraphy. The data is collected through a wearable device that can be worn for several days, and based on the outcome, the trained sleep professional will know how to direct the subject to the most appropriate treatment path for their patient. Not only that. It will finally be possible, then, to verify, through successive measurements, the improvements in the sleep profile obtained through the therapy adopted: this technique is in fact an objective instrumental evaluation, which, side by side with traditional evaluation systems, such as questionnaires, by their nature, subjective, allows a ‘more in-depth and complete investigation of the subject.
Sleep disorders and screening
According to the World Health Organization (WHO), insomnia ranks 11th on the list of major brain disorders. In Europe, it is estimated that between 6 -12% of the population is affected by sleep disorders, contributing to a very high socio-economic burden, amounting to 50 billion euros in direct costs according to the most recent European guidelines .
It is the need to study sleep in large populations that pushed Sleepacta to work on the creation of a medical degree screening service for monitoring sleep quantity and quality in an objective manner: data is collected through commercial smartbands, which are minimally invasive and readily available on the market, and which makes their use suitable for different subjects of all ages (from children to the elderly) and also for different clinical profiles (such as psychiatric patients), and reworked through a validated medical algorithm.
Dormi as a new tool for screening
The value of Sleepacta lies in the science and clinical research of its algorithms and the possibility to apply it to virtually any smartband that insufficiently sensitive and capable of recording data evenly, on a per-minute basis. The “agnostic” nature of DORMI with respect to the device (used only for data collection), is due to the validation of the system obtained through more than 300 simultaneous data recordings collected with smartband/Dormi vs. the Gold-Standard (Polysomnography, PSG).
It is not only the screening and monitoring service that makes Sleepacta a truly innovative product, but also its applicability and usability as an automatic generator of reports : through an interface platform the healthcare professional receives a report with all the recorded parameters, along with graphical representations to facilitate the interpretation of the collected data.
The importance of good sleep
Why is good sleep so important? Typically, sleep disturbance is accompanied by diurnal impairment , having negative practical implications that affect the daily and working life of the subject. Thus, on one hand increasing, for example, the risk of car accidents, injuries, errors and accidents at work; and on the other hand reducing productivity at work. The numbers speak for themselves: sleep deprivation is responsible for at least 20% of road accidents (due to daytime sleepiness) ; It is associated with hastiness  of the subject, reduced school performance in children  and reduced work performance in adults (increased accidents at work), as well as , in the long term, it is also related to a higher incidence of cardiovascular diseases (hypertension, atrial fibrillation, ischemia, pulmonary embolism).
When do we talk about insomnia? It is considered Chronic insomnia disorder when this occurs at least three times a week, for three consecutive months. Not to be confused with sporadic episodes that may occur before specific events (such as an examination or hospitalization) and resolve within a few days. In fact, diurnal impairment is also considered crucial to diagnosing this disorder today.
The Gold Standard examination for diagnosing sleep disorders is Polysomnography (PSG), but it has many limitations, well known to sleep professionals and their patients. Polysomnography is expensive, operator-dependent, complex and invasive: typically it cause itself a disturbed sleep. Actigraphy, on the other hand, allows sleep assessment under “naturalistic” conditions , thus allowing prolonged monitoring over time (up to seven days or more) and repeatable due to the very low intrusiveness. Actigraphy is recognized by the European sleep guidelines1 as an accepted diagnostic tool in the determination of sleep-wake rhythm; although accurate and precise, it is non-invasive, being a “Smartband,” and thus patient compliance to therapy is extremely high.